Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands

Oct. 18, 2004

Neurogen presents novel GABA-A receptor modulators

Oct. 18, 2004

New analgesic vanilloid VR1 antagonists discovered at Merck

Oct. 18, 2004

Extension study results for PBT-1 in Alzheimer's

Oct. 15, 2004

Expert analysis supports continued development of ENT-103

Oct. 15, 2004

Proof-of-concept study of NPS-1776 in migraine fails to meet primary endpoint

Oct. 15, 2004

Launches and court orders for generic gabapentin

Oct. 15, 2004

Enrollment completed in adult insomnia phase II study of SO-101

Oct. 15, 2004

New analgesic agents identified by Italian researchers

Oct. 15, 2004

New Nurr1 activators with potential utility in PD therapy

Oct. 13, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...